A Study Of BOTOX For The Treatment Of Glabellar Lines
NCT00408785
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
256
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
Botulinum Toxin Type A
DRUG:
sodium chloride
Sponsor
GlaxoSmithKline